NCT02824913View on ClinicalTrials.gov

Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

PHASE2TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Dry Eye Disease

Interventions

DRUG

P-321 Ophthalmic Solution

DRUG

P-321 Ophthalmic Solution placebo

Trial Locations (1)

33324

Bascom Palmer Eye Institute, University of Miami Health System, Plantation

Sponsors

Lead Sponsor

Parion Sciences

All Listed Sponsors

lead

Parion Sciences

INDUSTRY

NCT02824913 - Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease | Biotech Hunter | Biotech Hunter